The approach to Berger's disease - An IgA-induced nephropathy
DOI:
https://doi.org/10.33448/rsd-v13i10.47026Keywords:
Berger's disease, IgA nephropathy, Propaedeutics.Abstract
Introduction: Berger's disease is a nephropathy characterized by the deposition of IgA in the renal mesangium, which can progress to chronic renal failure, a fact that justifies the relevance of its clinical approach. Objectives: This study aims to review contemporary and multidisciplinary approaches to the diagnosis and treatment of IgA nephropathy, also known as Berger's disease, highlighting recent advances and scientific gaps. Materials and Methods: This is an integrative literature review on the general clinical characteristics of IgA-induced nephropathy. The PICO strategy was used to develop the guiding question. In addition, the descriptors “Berger's disease”; “IgA nephropathy”; “Propaedeutics” were cross-referenced in the National Library of Medicine (PubMed MEDLINE), Scientific Electronic Library Online (SCIELO), Ebscohost, Google Scholar and Virtual Health Library (VHL) databases. Results and Discussion: The articles analysed showed that the pathophysiology of Berger's disease is characterized by the aberrant action of the immune system, which favours the deposition of IgA in the kidneys. The clinical picture is varied and stems from the immune-mediated inflammatory process. The diagnosis of IgA nephropathy is confirmed by renal biopsy, which detects immunocomplexes under microscopy. Conclusion: Berger's disease is an immune-mediated disease with a complex pathophysiology and a variable clinical picture, which can be mild or severe. Diagnosis is based on a combination of clinical data and complementary tests, and treatment includes various pharmacological measures.
Downloads
References
Brum, C. D., Zuge, S. S., Rangel, R. F., Freitas, H. D., & Pieszak, G. M. (2015). Revisão narrativa da literatura: aspectos conceituais e metodológicos na construção do conhecimento da enfermagem. Metodologias da pesquisa para a enfermagem e saúde: da teoria à prática. Porto Alegre: Moriá.
Campos, M. F., Martins, L. M., Sanches, P. L. L. C., de Almeida, E. N. G., de Oliveira, C. A. L., Campos, N. R. P., ... & de Oliveira, R. U. (2024). Fisiopatologia e clínica da Nefropatia por IgA: Uma revisão de literatura. Research, Society and Development, 13(7), e9113746378-e9113746378.
Chen, T., Li, X., Li, Y., Xia, E., Qin, Y., Liang, S., ... & Liu, Z. (2019). Prediction and risk stratification of kidney outcomes in IgA nephropathy. American journal of kidney diseases, 74(3), 300-309.
Coppo, R. (2018). Treatment of IgA nephropathy: Recent advances and prospects. Nephrologie & therapeutique, 14, S13-S21.
Floege, J., Rauen, T., & Tang, S. C. (2021, October). Current treatment of IgA nephropathy. In Seminars in immunopathology (pp. 1-12). Springer Berlin Heidelberg.
Gleeson, P. J., O'Shaughnessy, M. M., & Barratt, J. (2023). IgA nephropathy in adults—treatment standard. Nephrology Dialysis Transplantation, 38(11), 2464-2473.
Knoppova, B., Reily, C., King, R. G., Julian, B. A., Novak, J., & Green, T. J. (2021). Pathogenesis of IgA nephropathy: current understanding and implications for development of disease-specific treatment. Journal of Clinical Medicine, 10(19), 4501.
Maixnerova, D., & Tesar, V. (2020). Emerging modes of treatment of IgA nephropathy. International journal of molecular sciences, 21(23), 9064.
Monteiro, R. C. (2018). Recent advances in the physiopathology of IgA nephropathy. Nephrologie & therapeutique, 14, S1-S8.
Moriyama, T. (2019). Clinical and histological features and therapeutic strategies for IgA nephropathy. Clinical and Experimental Nephrology, 23, 1089-1099.
Nihei, Y., Suzuki, H., & Suzuki, Y. (2023). Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy. Frontiers in Immunology, 14, 1165394.
Paula, A. C. A. L., Victória, P. H. S., Bernardes, M. E. C., Pizani, I. A., Campos, F. R. P., Neto, N. P. L., ... & Quadros, S. F. P. (2024). Doença de Berger: principais aspectos da doença. Journal of Social Issues and Health Sciences (JSIHS), 1(5).
Penfold, R. S., Prendecki, M., McAdoo, S., & Tam, F. W. (2018). Primary IgA nephropathy: current challenges and future prospects. International journal of nephrology and renovascular disease, 137-148.
Perše, M., & Večerić-Haler, Ž. (2019). The role of IgA in the pathogenesis of IgA nephropathy. International journal of molecular sciences, 20(24), 6199.
Rajasekaran, A., Julian, B. A., & Rizk, D. V. (2021). IgA nephropathy: an interesting autoimmune kidney disease. The American journal of the medical sciences, 361(2), 176-194.
Reich, H. N., & Floege, J. (2022). How I treat IgA nephropathy. Clinical Journal of the American Society of Nephrology, 17(8), 1243-1246.
Sallustio, F., Curci, C., Di Leo, V., Gallone, A., Pesce, F., & Gesualdo, L. (2019). A new vision of IgA nephropathy: the missing link. International journal of molecular sciences, 21(1), 189.
Schena, F. P., & Nistor, I. (2018, September). Epidemiology of IgA nephropathy: a global perspective. In Seminars in nephrology 38(5), 435-442). WB Saunders.
Selvaskandan, H., Cheung, C. K., Muto, M., & Barratt, J. (2019). New strategies and perspectives on managing IgA nephropathy. Clinical and experimental nephrology, 23, 577-588.
Tortajada, A., Gutierrez, E., Pickering, M. C., Terente, M. P., & Medjeral-Thomas, N. (2019). The role of complement in IgA nephropathy. Molecular immunology, 114, 123-132.
Yeo, S. C., Cheung, C. K., & Barratt, J. (2018). New insights into the pathogenesis of IgA nephropathy. Pediatric Nephrology, 33, 763-777.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Bruna Carvalho Veloso; Victor Fernando Silva; Leandro Gervasio Antunes Cacau; Mariana Lúcio Gallo
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
